Azenta, Inc.

AZTA Healthcare Medical Instruments & Supplies

Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

34.09 2.43 −6.65%
Market cap
$1.6B
P/E
0.0×
Fwd P/E
−6.2×
Dividend yield
—
F-score
7/9
Altman Z
3.85
Beneish M
−2.63
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 6 5 5
ROE
(3.19%) (3.51%) (10.65%) (7.72%)
ROA
(2.68%) (2.93%) (8.79%) (6.31%)
ROIC
(1.21%) (1.22%) (9.23%) (9.27%)
Return on Tangible Assets
(8.93%) (9.06%) (27.02%) (21.15%)
Average Days of Receivables
93.37 92.11 84.54 88.91
Free Cash Flow per Share
0.84 0.67 0.65 0.22
Free Cash Flow
38.32 30.93 30.05 9.88
Other line items

Show all line items

Columns are period end dates